English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Objectives: To survery the plasma NT-proBNP concentration, the correlation between NT-proBNP concentration and the New York Pediatric Heart Failure Index (NYU PHFI) in children with dilated cardiomyopathy. Comment on the association of NT-proBNP with the level of left ventricular dilatation and systolic function in the follow up of children with dilated cardiomyopathy. Method: Prospective, descriptive study. Results: At the time of diagnosis, 32 out of 33 patients (97%) had an NTproBNP level higher than 97,5 th percentile. The log NT-proBNP was significantly positively correlated with PHFI (r = 0.84; P <0.001). The log NT-proBNP wasalso positively correlated with LVED (r = 0.519; p <0.001), was negatively correlated with LVEF (r = -0.736; p <0.001) and LVFS (r = 0.737; p <0.001. The initial levels of serum NT-proBNP were not different from three progressed groups. However, at 3 months after diagnosis, the NT-proBNP of the improved group was significantly different from each other. Conclusion: NT-proBNP is an excellentbiomarker used to diagnose and assess cardiac insufficiency inthe follow up of children with dilated cardiomyopathy.

The Value of NT-proBNP the Follow - up of Children with Dilated Cardiomyopathy